Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
448.00    13.50 (3.11%)
Bid:
447.00
Ask:
450.00
Spread: 3.00 (0.671%)
Market Cap: £220.33m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Interim Management Statement

26 Oct 2012 07:00

RNS Number : 5898P
Zotefoams PLC
26 October 2012
 



26 October 2012

 

Zotefoams plc

("Zotefoams" or "the Company")

 

Interim Management Statement for the Quarter ended 30 September 2012

 

26 October 2012 - Zotefoams, which manufactures and sells high-performance foams, today announces its interim management statement for the third quarter ended 30 September 2012.

 

Third quarter Polyolefin foam sales increased by approximately 3% in constant currency compared to the same period last year. Sales growth in North America and Rest of World was around 6% while we experienced more modest growth in UK and Continental Europe. The impact of a weaker euro reduced the sterling value of European sales by approximately 10% while there was a small positive impact on sales elsewhere from relative US dollar strength compared with the third quarter in 2011.

 

In the third quarter of 2011 there was high demand for our T-Tubes® insulation products and, due to timing of projects, comparative sales were much lower in 2012. As a result, revenue from our High-Performance Polymers ("HPP") segment was approximately 20% below the same period last year despite an increase in sales of our patented ZOTEK® F fluoropolymer foams. While sales in HPP have historically been subject to short term fluctuations, we remain confident of strong underlying growth in this segment, much of which is to the aviation market.

 

In July and August 2012 MuCell Extrusion LLC ("MEL"), which licenses foaming technology, made important advances within the film and sheet markets. Agreements with Dow Chemical and Styron to license-in their complementary patents have enhanced our ability to offer attractive licences in packaging technology, and activity and interest levels have increased as a direct result. The development pipeline of new projects continues to grow from a small base and in the medium term we expect good progress in conversion of additional signed MEL licences. Currently MEL is a developmental business which is cash generative and we are increasing investment commensurate with our expectations for growth over the coming years.

 

For the third quarter the euro-denominated price of low density polyethylene (LDPE), our main raw material, was at a similar average price compared to the same period last year.

 

The Company continues to progress, with a forward order book into early 2013. Although we are mindful of the uncertain economic environment and the potential for movements in exchange rates to have a translation impact on our reported results, the Board remains confident of a satisfactory outcome for the year and continued progress in the future.

 

 

Enquiries:

Zotefoams plc

0208-664-1600

David Stirling, Managing Director

Clifford Hurst, Finance Director

FTI Consulting

0207-831-3113

Ben Brewerton, John Dineen, Victoria Foster Mitchell

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular material technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces lightweight foams in Croydon, UK and Kentucky, USA for diverse markets worldwide through its global sales force. Zotefoams also owns and licenses patented MuCell® microcellular foam technology from a base in Massachusetts, USA to customers worldwide and sells T-Tubes® advanced insulation systems made from its patented ZOTEK® fluoropolymer foams.

 

www.zotefoams.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUVSBRUSARUAA
Date   Source Headline
17th May 20079:14 amRNSDirector/PDMR Shareholding
14th May 20075:55 pmRNSDirectors' Shareholdings
14th May 20073:14 pmRNSResult of AGM
10th May 20077:01 amRNSAGM Statement
19th Apr 20071:47 pmRNSDirector/PDMR Shareholding
13th Apr 20074:31 pmRNSDirector/PDMR Shareholding
12th Apr 20072:34 pmRNSDocuments submission
5th Apr 200712:34 pmRNSBlock Listing Application
20th Mar 20074:18 pmRNSHolding(s) in Company
6th Mar 20077:01 amRNSFinal Results
27th Feb 20072:12 pmRNSHolding(s) in Company
22nd Feb 200710:35 amRNSDirectorate Appointment
18th Dec 20064:58 pmRNSVoting rights & capital
14th Dec 20067:01 amRNSPeriod End Trading Update
5th Dec 20064:50 pmRNSDirector/PDMR Shareholding
17th Nov 20065:00 pmRNSDirector/PDMR Shareholding
13th Oct 20067:00 amRNSDirectorate Change
8th Aug 20067:00 amRNSInterim Results
29th Jun 200611:14 amRNSTrading Statement
15th Jun 20069:56 amRNSBlocklisting Interim Review
23rd May 20062:02 pmRNSResult of AGM
16th May 20067:01 amRNSAGM Statement
11th May 20069:04 amRNSAnnual Information Update
20th Apr 20062:30 pmRNSDirector/PDMR Shareholding
19th Apr 200611:54 amRNSHolding(s) in Company
7th Apr 200612:45 pmRNSAnnual Report and Accounts
30th Mar 20064:14 pmRNSDirectorate Change
29th Mar 200612:27 pmRNSDirector/PDMR Shareholding
29th Mar 200610:49 amRNSDirector/PDMR Shareholding
22nd Mar 20065:14 pmRNSDirector/PDMR Shareholding
21st Mar 20062:37 pmRNSRe Agreement
14th Mar 20067:02 amRNSFinal Results
23rd Dec 200511:24 amRNSDirector/PDMR Shareholding
23rd Dec 200510:19 amRNSDirector/PDMR Shareholding
21st Dec 20055:57 pmRNSHolding(s) in Company
21st Dec 20055:32 pmRNSHolding(s) in Company
15th Dec 20057:00 amRNSPeriod End Trading Update
12th Dec 20054:12 pmRNSBlocklisting Interim Review
22nd Nov 200511:37 amRNSDirector/PDMR Shareholding
2nd Nov 20057:01 amRNSTrading Statement
26th Aug 200512:00 pmRNSUpdate on Directorate
18th Aug 20057:00 amRNSUpdate on Discussions
18th Aug 20057:00 amRNSInterim Results
3rd Aug 200511:23 amRNSRule 8.1- Zotefoams PLC
2nd Aug 200511:14 amRNSRule 8.1- Zotefoams PLC
20th Jul 200511:49 amRNSRule 8.1- Zotefoams PLC
9th Jun 20058:36 amRNSAdditional Listing
3rd May 20055:00 pmRNSHolding(s) in Company
28th Apr 20057:03 amRNSAGM Statement
24th Mar 200511:59 amRNSDocuments on Display

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.